BioMed Research International / 2022 / Article / Tab 1 / Research Article
Effects of Neurodynamic Mobilization on Health-Related Quality of Life and Cervical Deep Flexors Endurance in Patients of Cervical Radiculopathy: A Randomized Trial Table 1 Comparison of craniocervical flexion test and 8 domains of SF 36 within the experimental group.
Variable — Interquartile range Mean ranka Chi-square ( ), valuea Post hoc analysis scoreb valueb Craniocervical flexion (mmHg) Base line 21 (20 to 24) 1.07 78.28, Pre and midtreatment -5.56 <0.017 After 2nd week 24 (24 to 26) 2.10 Mid and posttreatment -5.15 <0.017 After 4th week 26 (24 to 28) 2.83 Pre and posttreatment -5.78 <0.017 Physical functioning–SF36 Baseline 35 (20 to 55) 1.15 73.92, Pre and midtreatment -4.59 <0.017 After 2nd week 57 (35 to 70) 1.94 Mid and posttreatment -5.43 <0.017 After 4th week 75 (60 to 85) 2.91 Pre and posttreatment -5.46 <0.017 Role limitation due to physical health–SF36 Baseline 0 (0 to 25) 1.28 66.72. Pre and midtreatment -4.38 <0.017 After 2nd week 25 (25 to 50) 1.91 Mid and posttreatment -5.01 <0.017 After 4th week 62.5 (50 to 100) 2.81 Pre and posttreatment -5.49 <0.017 Role limitation due to emotional problem–SF36 Baseline 0 (0 to 33.3) 1.59 36.20, Pre and midtreatment -2.68 <0.017 After 2nd week 33.3 (0 to 66.7) 1.89 Mid and posttreatment -3.72 <0.017 After 4th week 66.7 (33.3 to 100) 2.52 Pre and posttreatment -4.49 <0.017 Energy/fatigue–SF36 Baseline 45 (35 to 50) 1.18 61.82, Pre and midtreatment -4.56 <0.017 After 2nd week 55 (45 to 60) 2.03 Mid and posttreatment -4.95 <0.017 After 4th week 60 (50 to 75) 2.78 Pre and posttreatment -5.21 <0.017 Emotional wellbeing–SF36 Baseline 52 (44 to 60) 1.45 36.96, Pre and midtreatment -3.83 <0.017 After 2nd week 56 (52 to 64) 1.94 Mid and posttreatment -4.30 <0.017 After 4th week 66 (53 to 75) 2.60 Pre and posttreatment -4.61 <0.017 Social functioning–SF36 Baseline 43.75 (37.5 to 62.5) 1.38 53.26, Pre and midtreatment -3.91 <0.017 After 2nd week 62.50 (50 to 75) 1.89 Mid and posttreatment -5.06 <0.017 After 4th week 75 (62.5 to 87.5) 2.74 Pre and posttreatment -4.95 <0.017 Pain–SF36 Baseline 45 (43.1 to 45) 1.34 61.10, Pre and midtreatment -4.26 <0.017 After 2nd week 55 (45 to 66.87) 1.92 Mid and posttreatment -4.97 <0.017 After 4th week 67.5 (55 to 86.87) 2.74 Pre and posttreatment -5.17 <0.017 General health–SF36 Baseline 40 (35 to 55) 1.34 63.18, Pre and midtreatment -3.79 <0.017 After 2nd week 52.5 (40 to 65) 1.76 Mid and posttreatment -5.54 <0.017 After 4th week 75 (50 to 83.75) 2.90 Pre and posttreatment -5.56 <0.017
a Friedman test statistics, b post hoc analysis.